default author photo

Gaurav Kwatra

Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases

SCHOLARLY PAPERS

2

DOWNLOADS

77

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Efficacy of WRSs2, a Live-Attenuated Shigella sonnei Vaccine, Against Shigellosis in a Controlled Human Infection Model: A Double-Blind, Randomized Trial

Number of pages: 27 Posted: 02 Mar 2026
Emory University, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Emory University, Emory University, Emory University, Emory University, The Emmes Company, The Emmes Company, The Emmes Company, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Walter Reed Army Institute of Research, Walter Reed Army Institute of Research, United States Department of the Navy - Naval Medical Research Center - Silver Spring, Walter Reed Army Institute of Research, Walter Reed Army Institute of Research, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases and Independent
Downloads 42 (1,183,237)

Abstract:

Loading...

Shigella, WRSs2 vaccine, efficacy, controlled human infection model, randomized controlled trial

2.

Immunogenicity through to Five Years of Age Following a Single Compared with Two Dose Primary Series Followed by a Booster Dose of 10-Valent or 13-Valent Pneumococcal Conjugate Vaccine during Infancy: An Open-Label, Randomised, Non-Inferiority Trial

Number of pages: 18 Posted: 23 Apr 2026
University of the Witwatersrand, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, University of Birmingham - Clinical Immunology Service, University of Birmingham - Institute of Cancer and Genomic Sciences and University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit
Downloads 35 (1,263,436)

Abstract:

Loading...

Pneumococcal conjugate vaccine, reduced-dose schedule, non-inferiority, long-term immunogenicity, South Africa, HIV-unexposed, PCV13, PCV10